A shadow economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Experimental Drug Acquiring Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.
Some professionals stated the demand for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned associated keywords and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Trading Operations
Research also found communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.
After moments of entering one group, a seller posted contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Details and Pricing
Within these groups, posts show dark colored parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram stated it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant health risks”.
